These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 18766904)

  • 21. Dose-dependent inhibition of virus rescue from lymphocytes latently infected with turkey herpesvirus or Marek's disease virus.
    Calnek BW; Shek WR; Schat KA; Fabricant J
    Avian Dis; 1982; 26(2):321-31. PubMed ID: 6285880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies on pathogenical, virological and serological properties of Marek's disease virus isolated from Japanese quail and chicken.
    Imai K; Yuasa N; Furuta K; Narita M; Banba H; Kobayashi S; Horiuchi T
    Avian Pathol; 1991 Mar; 20(1):57-65. PubMed ID: 18679999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epizootiology of Marek's disease. 3. The interrelationship of virus pathogenicity, antibody and the incidence of Marek's disease.
    Jackson CA; Biggs PM; Bell RA; Lancaster FM; Milne BS
    Avian Pathol; 1976; 5(2):105-23. PubMed ID: 18777336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription.
    Quéré P; Rivas C; Ester K; Novak R; Ragland WL
    Arch Virol; 2005 Mar; 150(3):507-19. PubMed ID: 15592893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation between strains of Marek's disease virus and turkey herpesvirus by immunofluorescence assays.
    Bulow VV; Biggs PM
    Avian Pathol; 1975; 4(2):133-46. PubMed ID: 18777301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral pathogenesis in chicken embryos and tumor induction in chickens after in ovo exposure to serotype 1 Marek's disease virus.
    St Hill CA; Sharma JM
    Avian Dis; 2000; 44(4):842-52. PubMed ID: 11195638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro infection of lymphocytes with Marek's disease virus.
    Calnek BW; Schat KA; Shek WR; Chen CL
    J Natl Cancer Inst; 1982 Sep; 69(3):709-13. PubMed ID: 6287084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marek's disease vaccines.
    Calnek BW
    Dev Biol Stand; 1982; 52():401-5. PubMed ID: 6299850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
    Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
    Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative pathogenicity of Marek's disease virus and vaccine virus strains in chickens: macroscopical aspects.
    Maas HJ; Orthel FW; Rispens BH; Tittes EV; De Kort MF; Vreede-Groenewegen AE; Jansen J; Hartog L
    Avian Pathol; 1978 Jan; 7(1):61-78. PubMed ID: 18770360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function.
    Reddy SM; Lupiani B; Gimeno IM; Silva RF; Lee LF; Witter RL
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7054-9. PubMed ID: 11997455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marek's disease virus (Kekava strain) replication in chickens, chick embryos and cell cultures.
    Yakovleva LS; Mazurenko NP; Gunenkova NK; Vinogradov VN; Pavlovskaya AI; Chernyakhovskaya IY
    Acta Virol; 1975 Jul; 19(4):293-8. PubMed ID: 241226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a cell line system susceptible to infection with vaccine strains of MDV.
    Abujoub AA; Williams DL; Reilly JD
    Acta Virol; 1999; 43(2-3):186-91. PubMed ID: 10696443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge.
    Islam AF; Wong CW; Walkden-Brown SW; Colditz IG; Arzey KE; Groves PJ
    Avian Pathol; 2002 Oct; 31(5):449-61. PubMed ID: 12427339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a sustainable chick cell line infected with Marek's disease virus.
    Abujoub A; Coussens PM
    Virology; 1995 Dec; 214(2):541-9. PubMed ID: 8553556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of Marek's disease: early appearance of Marek's disease tumor-associated surface antigen in infected chickens.
    Murthy KK; Calnek BW
    J Natl Cancer Inst; 1978 Sep; 61(3):849-54. PubMed ID: 357748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.